Physician profile
Hilltone Hui
NPI 1396005252
$3,600.81
in general payments reported to CMS, 2019-2025
17 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,863 · 2022: $1,102 · 2023: $162 · 2024: $46.04 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $850.57 | 2021-2025 | Nexletol |
| Gilead Sciences, INC. | $488.09 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $466.38 | 2021 | |
| Amgen INC. | $326.26 | 2021-2025 | Evenity, Prolia |
| Biohaven Pharmaceutical Holding Company LTD. | $285.11 | 2022 | |
| Glaxosmithkline, LLC. | $264.21 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $240.40 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.96 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $118.02 | 2021 | |
| Ibsa Pharma INC. | $116.67 | 2022 | |
| Ethicon US, LLC | $49.65 | 2025 | Stratafix, Vistaseal, Evarrest |
| Horizon Therapeutics Plc | $48.03 | 2021 | |
| Astellas Pharma US INC | $24.98 | 2024 | Veozah |
| Phathom Pharmaceuticals, INC. | $24.74 | 2025 | Voquezna |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.06 | 2024 | Mounjaro |
| Amarin Pharma, INC. | $18.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilltone Hui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.